Sunday, September 20, 2020

DCGI approves commercial launch of low cost COVID-19 test 'Feluda'

The Drugs Controller General of India has approved the commercial launch of 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of Scientific and Industrial Research (CSIR) said on Saturday.

from IndiaTV India: Google News Feed https://ift.tt/2EkOtJW
via

No comments:

Post a Comment

Please do not enter spam link in the comment box. Suggestions are invited for improvement.

Republic Day 2024: French band, marching contingent and Rafale jets participate in parade | WATCH

Republic Day 2024 : As India's 75th Republic Day Parade kicked off in the national capital, a 30-member band contingent and a marching c...